HPV DNA patterns and disease implications in the follow-up of patients treated for HPV16 high-grade carcinoma in situ

被引:13
作者
Cricca, M
Venturoli, S
Morselli-Labate, AM
Costa, S
Santini, D
Ambretti, S
Musiani, M
Zerbini, M
机构
[1] Univ Bologna, Dept Clin & Expt Med, Microbiol Sect, I-40138 Bologna, Italy
[2] Univ Bologna, Dept Internal Med & Gastroenterol, I-40138 Bologna, Italy
[3] St Orsola Marcello Malpighi Hosp, Dept Obstet & Gynecol, Bologna, Italy
[4] St Orsola Marcello Malpighi Hosp, Dept Pathol, Bologna, Italy
关键词
HPV16; molecular parameters; disease implications;
D O I
10.1002/jmv.20567
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Twenty-five patients with high-grade cervical lesions associated with HPV16 infection were studied at the time of surgical treatment and followed up after conization. Before surgical treatment, the following parameters were analyzed: (1) physical status of HPV16 DNA, (2) viral load, (3) cytological presentation confirmed by histological diagnosis, and (4) colposcopy. At the time of conization, (5) margin presentation, and (6) cone biopsy were evaluated. At each stage of the follow-up (7) physical status of HPV16 DNA, (8) viral load, (9) cytological test, and (10) colposcopy were repeated. The correlation between the different parameters was examined. Significant differences in the viral loads were observed between integrated and episomal forms and between the coexisting integrated/episomal forms and the only episomal form, while no statistically significant differences were observed between integrated and coexisting forms. At the first stage of follow-up, 11 of 25 patients analyzed (44%) were negative to HPV DNA cytology and colposcopy tests, 13 of the 25 (52%) were HPV16 DNA negative, 17 (68%) cytology negative, and 20 (80%) colposcopy negative. At the closing stage, 15 of 25 subjects (60%) were negative to all three tests, 16 of the 25 (64%) were HPV16 DNA negative, 19 (76%) cytology negative, and 20 colposcopy negative (80%). These observations suggest that in surgery treated patients the viral clearance at the closing stage of follow-up was unrelated to the HPV DNA physical status and to the viral load before treatment, but was associated significantly with the effectiveness of surgery treatment, in particular with margin cone presentation.
引用
收藏
页码:494 / 500
页数:7
相关论文
共 25 条
[1]   Human papilloma virus testing in patient follow-up post cone biopsy due to high-grade cervical intraepithelial neoplasia [J].
Almog, B ;
Gamzu, R ;
Kuperminc, MJ ;
Levin, I ;
Fainaru, O ;
Niv, J ;
Bar-Am, A .
GYNECOLOGIC ONCOLOGY, 2003, 88 (03) :345-350
[2]   Follow-up by combined cytology and human papillomavirus testing for patients post-cone biopsy: results of a long-term follow-up [J].
Bar-Am, A ;
Gamzu, R ;
Levin, I ;
Fainaru, O ;
Niv, J ;
Almog, B .
GYNECOLOGIC ONCOLOGY, 2003, 91 (01) :149-153
[3]   USE OF SEMIQUANTITATIVE PCR FOR HUMAN PAPILLOMAVIRUS DNA TYPE-16 TO IDENTIFY WOMEN WITH HIGH-GRADE CERVICAL DISEASE IN A POPULATION PRESENTING WITH A MILDLY DYSKARYOTIC SMEAR REPORT [J].
BAVIN, PJ ;
GILES, JA ;
DEERY, A ;
CROW, J ;
GRIFFITHS, PD ;
EMERY, VC ;
WALKER, PG .
BRITISH JOURNAL OF CANCER, 1993, 67 (03) :602-605
[4]   AMPLIFICATION OF HUMAN PAPILLOMAVIRUS TYPE-16 AND TYPE-18 IN INVASIVE CERVICAL-CANCER [J].
BERUMEN, J ;
UNGER, ER ;
CASAS, L ;
FIGUEROA, P .
HUMAN PATHOLOGY, 1995, 26 (06) :676-681
[5]   Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization [J].
Costa, S ;
De Simone, P ;
Venturoli, S ;
Cricca, M ;
Zerbini, ML ;
Musiani, M ;
Terzano, P ;
Santini, D ;
Cristiani, P ;
Syrjänen, S ;
Syrjdnen, K .
GYNECOLOGIC ONCOLOGY, 2003, 90 (02) :358-365
[6]   HUMAN PAPILLOMAVIRUS TYPE-16 DNA IN CERVICAL SMEARS AS PREDICTOR OF HIGH-GRADE CERVICAL-CANCER [J].
CUZICK, J ;
TERRY, G ;
HO, L ;
HOLLINGWORTH, T ;
ANDERSON, M .
LANCET, 1992, 339 (8799) :959-960
[7]   TYPE-SPECIFIC HUMAN PAPILLOMAVIRUS DNA IN ABNORMAL SMEARS AS A PREDICTOR OF HIGH-GRADE CERVICAL INTRAEPITHELIAL NEOPLASIA [J].
CUZICK, J ;
TERRY, G ;
HO, L ;
HOLLINGWORTH, T ;
ANDERSON, M .
BRITISH JOURNAL OF CANCER, 1994, 69 (01) :167-171
[8]   Disruption of the E1 and E2 reading frames of HPV 16 in cervical carcinoma is associated with poor prognosis [J].
Kalantari, M ;
Karlsen, F ;
Kristensen, G ;
Holm, R ;
Hagmar, B ;
Johansson, B .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1998, 17 (02) :146-153
[9]   Human papillomavirus type 16 status in cervical carcinoma cell DNA assayed by multiplex PCR [J].
Lukaszuk, K ;
Liss, J ;
Wozniak, I ;
Emerich, J ;
Wójcikowski, C .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (02) :608-612
[10]  
MANOS MM, 1989, CANCER CEL, V7, P209